Back to Agenda
Effective and Balanced Risk Communication
Session Chair(s)
Dolores Montero, DrMed, MD
Head Division Pharmacology and Pharmacoepidemiology, Spanish Agency Of Medicines and Medical Devices, Spain
Risk communication is an essential tool for risk minimisation. This session will provide insight on the patient’s perception, how communication can be tailored to the differences audiences and what are European countries doing in order to improve such communications.
Speaker(s)
D.K.Theo Raynor, PhD, MPharm
Professor of Pharmacy Practice, University of Leeds, United Kingdom
Does Transparency in Medicines Information Deliver Benefit to Patients?
Sabine Straus, MD, PhD, MSc
Former PRAC Chair, Medicines Evaluation Board (MEB), Netherlands
Different Approaches for Different Audiences
Dolores Montero, DrMed, MD
Head Division Pharmacology and Pharmacoepidemiology, Spanish Agency Of Medicines and Medical Devices, Spain
Risk Communication in the EU - The SCOPE Joint Action
Have an account?